(Huntersville, N.C.) BioCytics, Inc., is pleased to announce it has been awarded accreditation by the College of American Pathologists (CAP) for its Circulating Tumor Cell (CTC) Enumeration assay. CTCs are cancer cells that travel through the body via the bloodstream. They are thought have broken free from a solid tumor. The FDA has approved the use of the CellSearch® CTC test for monitoring to predict overall survival in metastatic breast, prostate, and colorectal cancer patients. (more…)

(Raleigh, N.C.) PRA, a leading Clinical Research Organization, announces the recent opening of a new office in Lund, Sweden to support continued growth in the area. The facility enhances local staff members’ ability to provide quality clinical services across Scandinavia. The Swedish office is located in the thriving region of Öresund, a hub for life science businesses. Öresund is centrally situated in the Medicon Valley, widely known as one of Europe’s primary centers for biotech and pharmaceutical activity. The region is also home to several top universities, providing access to leading academic research. (more…)

(Research Triangle Park, N.C.) NCTechNews, North Carolina’s technology news source, will be blogging live from the BIO International Convention in Washington, D.C. June 27-30 to cover major trends affecting the life sciences community. The BIO International Convention is the largest global event of its kind, attracting the biggest names in biotech and featuring keynotes and sessions from key policymakers, scientists, CEOs, and celebrities, and the world’s largest biotechnology exhibition - the BIO Exhibition. (more…)

(Morrisville, N.C.) Clinipace Worldwide, a global digital clinical research organization (dCRO), and Swiss-based PFC Pharma Focus (PFC) today jointly announced a definitive merger agreement under which Clinipace Worldwide has acquired all outstanding shares of privately-held PFC and its subsidiaries. Based in Zurich, Switzerland - with offices in Germany, Israel and India - PFC is a pan-European contract research provider focused on drug and medical device development services and regulatory consulting. (more…)

(Research Triangle Park, N.C.) Alan Hendricker, Ph.D., Principal Scientist of Structural Chemistry, and Thomas Feinberg, Ph.D., Director of Structural Chemistry, at Catalent Pharma Solutions will have prominent roles at this year’s PQRI workshop entitled “Thresholds and Best Practices for Parenteral and Ophthalmic Drug Products (PODP).” The workshop will be held at the Hyatt Regency in Bethesda, MD on February 22-23, 2011. (more…)

(Raleigh, N.C.) d-Wise, provider of powerful business solutions for the unique challenges of the Life Sciences & Healthcare industries, has introduced Reveal™, an innovative, web-based search platform that quickly returns results across multiple clinical data systems. Working in partnership with Daiichi Sankyo, Inc., a global pharmaceutical company with a development and commercial headquarters located in New Jersey, d-Wise designed and developed a new software solution to enable the company’s researchers, administrators, managers and informatics directors to perform comprehensive exploration of its clinical data systems. (more…)

(Morrisville, N.C.) Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today that it recently closed its best year to date, achieving over 800% revenue growth since 2008. The company more than doubled its revenues in 2010 over the prior year, attributable to 16 new projects awarded from 12 new clients. (more…)

(Durham, N.C.) Health Decisions (www.HealthDec.com), a full-service clinical research organization (CRO) specializing in high-efficiency adaptive methods, will be represented by CEO Dr. Michael Rosenberg at the DIA 4th Annual Clinical Forum October 11 - 13 in Lisbon, Portugal. Dr. Rosenberg will address the Forum with a presentation titled “Adaptive Monitoring: Faster, Better e-Monitoring.” It will highlight the advantages and requirements of adopting innovative monitoring methods and technologies. (more…)

(Morrisville, N.C.) Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that it has been named to Inc. Magazine’s 29th annual Inc. 500, an exclusive ranking of the nation’s fastest-growing private companies. Ranked 485, Clinipace is listed among the most successful private companies that have experienced substantial revenue growth over a three year period (2006-2009). (more…)

(Durham, N.C.) Health Decisions (www.HealthDec.com, Booth 929), a full-service clinical research organization (CRO) specializing in high-efficiency adaptive solutions, announces that CEO Michael Rosenberg, MD, MPH will join a panel June 14 at the DIA Annual Meeting in Washington, DC. Centralized Monitoring: When Does It Make Sense? will focus on the advantages and requirements of monitoring programs that balance the needs of sponsor companies and investigative sites in phase IIIb to postmarket clinical studies. (more…)

(Durham, N.C.) Michael Rosenberg, founder and CEO of full-service clinical research organization (CRO) Health Decisions (www.HealthDec.com), will explore the implications of a fully adaptive clinical program—one which applies adaptive principles to both design and operations—at Adaptive Designs for Clinical Drug Development, to be held April 28 – 30 in Philadelphia, PA. The Summit will focus solely on adaptive clinical development, providing an opportunity for FDA members and research experts to determine the impact of the recently released FDA guidelines on the topic. (more…)

(Durham, N.C.) Health Decisions (www.HealthDec.com), a full-service clinical research organization (CRO) specializing in high-efficiency adaptive solutions, welcomes South Africa-based CRO ClinResearch to the Agile Clinical Network—a community of research partners formed to eliminate the information gaps and prolonged timelines inherent to complex global studies. (more…)